Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.900 |
None |
0.955 |
22 |
1
|
2000 |
2020 |
SYSTEMIC LUPUS ERYTHEMATOSUS 16
|
disease |
|
Disease or Syndrome
|
5
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Proteinuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
239
|
20
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Libman-Sacks Disease
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
59
|
|
0.300 |
None |
|
0 |
|
|
|
Nephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
296
|
40
|
0.130 |
None |
1.000 |
3 |
1
|
2010 |
2013 |
Cystic Fibrosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
852
|
704
|
0.100 |
None |
0.929 |
14 |
|
1990 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Photosensitivity of skin
|
phenotype |
Skin and Connective Tissue Diseases
|
Pathologic Function
|
91
|
3
|
0.100 |
None |
|
0 |
|
|
|
Thrombocytopenia
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
592
|
110
|
0.100 |
None |
|
0 |
|
|
|
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.100 |
None |
|
0 |
|
|
|
Anti-nuclear factor positive
|
phenotype |
Skin and Connective Tissue Diseases
|
Laboratory or Test Result
|
35
|
3
|
0.100 |
None |
|
0 |
|
|
|
Pleurisy
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
82
|
7
|
0.100 |
None |
|
0 |
|
|
|
Leukopenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
440
|
153
|
0.100 |
None |
|
0 |
|
|
|
Antiphospholipid antibody positivity
|
phenotype |
|
Finding
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Psychotic Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
560
|
179
|
0.100 |
None |
|
0 |
|
|
|
Arthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
1072
|
69
|
0.100 |
None |
|
0 |
|
|
|
SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
5
|
5
|
0.100 |
None |
|
0 |
2
|
|
|
Butterfly rash
|
phenotype |
Skin and Connective Tissue Diseases
|
Finding
|
13
|
|
0.100 |
None |
|
0 |
|
|
|
Anemia, Hemolytic
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
154
|
31
|
0.100 |
None |
|
0 |
|
|
|
Pericarditis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
51
|
6
|
0.100 |
None |
|
0 |
|
|
|
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.090 |
None |
1.000 |
9 |
|
2005 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.080 |
None |
1.000 |
8 |
|
2011 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.080 |
None |
1.000 |
8 |
|
2011 |
2017 |